Loading...

SGHT SIGHT SCIENCES INC Legal Disputes 8-K Filing

SGHT

SGHT

SIGHT SCIENCES INC

(SGHT)

2026 8-K

Financial Results Update

Patent Litigation Victory

Patent Infringement Case

Financial Update

Lease Amendment Details

Financial Results Update

Management Changes

TearCare Pricing Update

Loan Agreement Amendment

Cost Reduction Plan

Financial Statements

Financial Statements

Director Appointment

Financial Results

Executive Compensation

Financial Results

Management Changes

Medicare Coverage Update

Medicare Coverage Update

Earnings Reports

Annual Meeting of Stockholders

Medicare Coverage Determina...

Earnings Reports

Patent Infringement Verdict

Earnings Reports

Compensatory Arrangements o...

Loan Agreement with Hercule...

Lease Amendment

Delay of LCDs on Glaucoma S...

Medicare Administrative Con...

Financial Results Announcement

Evaluation of Guidance for ...

Cost Reduction Plan

Regulation FD Disclosure

Appointment of Chief Commer...

Financial Results

Annual Meeting of Stockholders

Reaffirmation of Revenue Gu...

Reaffirmation of Revenue Gu...

Investor Presentation

Financial Results Announcement

Appointment of Chief Financ...

Financial Results Announcement

Financial Results and Manag...

External Links:

On March 27, 2026, a court upheld a jury’s decision that Alcon willfully infringed on Sight Sciences' patents, awarding $34 million plus ongoing royalties of 10% of Hydrus revenue through 2028.

AI Assistant

SIGHT SCIENCES INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.